FDA.reportPublic FDA data

HEB Eye Drops

Manufacturer
H E B
Effective date
2023-01-27
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 21:38:53

Label at a glance#

ProductHEB Eye Drops
Active ingredientNAPHAZOLINE HYDROCHLORIDE, GLYCERIN
Label structure9 sections

Indications and uses

for the relief of redness of the eye due to minor eye irritations. for the temporary relief of burning and irritation due to the dryness of the eye. for the use as a protectant against further irritation or dryness of the eye

Dosage and administration

Instill 1 or 2 drops in the affected eye(s) up to 4 times daily.

Storage and handling

Store at room temperature.

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Glycerin 0.5%

Naphazoline hydrochloride 0.03%

Purpose

OTC - PURPOSE SECTION

Lubricant

Redness reliever

Uses

INDICATIONS & USAGE SECTION

  • for the relief of redness of the eye due to minor eye irritations.
  • for the temporary relief of burning and irritation due to the dryness of the eye.
  • for the use as a protectant against further irritation or dryness of the eye

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • if solution changes color or becomes cloudy

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

you have narrow angle glaucoma

When using this product

OTC - WHEN USING SECTION

  • To avoid contamination, do not touch tip of container to any surface.
  • Replace cap after using.
  • Overuse may produce increased redness of the eye
  • Pupils may become enlarged temporarily.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you experience eye pain
  • you experience changes in vision
  • you experience continued redness or irritation of the eye
  • condition worsens or persists for more than 72 hours

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Instill 1 or 2 drops in the affected eye(s) up to 4 times daily.

Other information

STORAGE AND HANDLING SECTION

Store at room temperature.

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, boric acid, disodium edetate hydrate, sodium borate, water for injection

Package label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

cartoncarton

package label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

cartoncarton

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
37808-56037808-560-02, 37808-560-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
NameUNIIKind
BENZALKONIUM CHLORIDEF5UM2KM3W7IACT
BORIC ACIDR57ZHV85D4IACT
SODIUM BORATE91MBZ8H3QOIACT
EDETATE DISODIUM7FLD91C86KIACT
WATER059QF0KO0RIACT
NAPHAZOLINE HYDROCHLORIDEMZ1131787DACTIB
GLYCERINPDC6A3C0OXACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f344ff26-4cf6-2f7a-e053-2a95a90abfbfb67925c0-8b14-787a-e053-2995a90a79b12023-01-27WarningsExact identifier
spl id: f344ff26-4cf6-2f7a-e053-2a95a90abfbf
spl set id: b67925c0-8b14-787a-e053-2995a90a79b1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.